Phytotherapy in the management of diabetes: a review
P Governa, G Baini, V Borgonetti, G Cettolin… - Molecules, 2018 - mdpi.com
Phytotherapy has long been a source of medicinal products and over the years there have
been many attempts to use herbal medicines for the treatment of diabetes. Several …
been many attempts to use herbal medicines for the treatment of diabetes. Several …
Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a …
Accumulating evidence implicates gut microbiota as promising targets for the treatment of
type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis …
type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis …
Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus
M Cortez-Navarrete, E Martínez-Abundis… - Journal of medicinal …, 2018 - liebertpub.com
An improvement in parameters of glycemic control has been observed with Momordica
charantia in patients with type 2 diabetes mellitus (T2DM). It is unknown whether this …
charantia in patients with type 2 diabetes mellitus (T2DM). It is unknown whether this …
An overview of anti-diabetic plants used in Gabon: Pharmacology and toxicology
BB Taika, M Bouckandou, A Souza… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance The management of diabetes mellitus management in
African communities, especially in Gabon, is not well established as more than 60% of …
African communities, especially in Gabon, is not well established as more than 60% of …
Modulation of gut microbiota and gut-generated metabolites by bitter melon results in improvement in the metabolic status in high fat diet-induced obese rats
J Bai, Y Zhu, Y Dong - Journal of functional foods, 2018 - Elsevier
The anti-obesity property of bitter melon powder (BMP) was investigated using a high-fat diet
(HFD) obesity model. Obese rats were fed a HFD and treated with BMP for 8 weeks. We …
(HFD) obesity model. Obese rats were fed a HFD and treated with BMP for 8 weeks. We …
[HTML][HTML] Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania
MB Krawinkel, C Ludwig, ME Swai, R Yang… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance Impaired glucose tolerance and diabetes mellitus have
become major health issues even in non-industrialized countries. As access to clinical …
become major health issues even in non-industrialized countries. As access to clinical …
Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus
RR Franco, D da Silva Carvalho, FBR de Moura… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance Plants preparations are used by traditional medicine in the
treatment of various diseases, such as type-2 diabetes mellitus. Some medicinal plants are …
treatment of various diseases, such as type-2 diabetes mellitus. Some medicinal plants are …
Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin‐Induced Diabetic Mice
Scope Momordica charantia (M. charantia) has antidiabetic effects, and cucurbitane‐type
triterpenoid is one of the compounds of M. charantia. This study aims to investigate whether …
triterpenoid is one of the compounds of M. charantia. This study aims to investigate whether …
An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome
Background Metabolic syndrome is the cluster of risk factors that leads to increased
episodes of cardiovascular disease (CVD). These risk factors include but are not limited to …
episodes of cardiovascular disease (CVD). These risk factors include but are not limited to …
Effect of bitter melon extracts on lipid levels in Japanese subjects: a randomized controlled study
H Kinoshita, Y Ogata - Evidence‐Based Complementary and …, 2018 - Wiley Online Library
Dyslipidemia is exemplified by high levels of low‐density lipoprotein cholesterol (LDL‐C)
and represents a risk factor for cardiovascular diseases and requires therapeutic …
and represents a risk factor for cardiovascular diseases and requires therapeutic …